Cardiovascular disease in peritoneal dialysis patients

Panminerva Medica

Volumn 51, Issue 3, 2009, Pages 151-161

  Fassett, R G ^a,b   Driver, R ^c   Healy, H ^a   Coombes, J S ^b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Cardiovascular diseases; Morbidity; Mortality; Peritoneal dialysis

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; EVIDENCE BASED MEDICINE; HUMAN; KIDNEY DISEASE; MORTALITY; PERITONEAL DIALYSIS; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME; CARDIOVASCULAR DISEASES; KIDNEY DISEASES;

CARDIOVASCULAR DISEASES; EVIDENCE-BASED MEDICINE; HUMANS; KIDNEY DISEASES; PERITONEAL DIALYSIS; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 76749125345     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (90)

1. Foley RN, Collins AJ. End-stage renal disease in the United States: an update from the United States Renal Data System. J Am Soc Nephrol 2007;18:2644-8.
2. Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 1998;32:853-906.
3. Vonesh EF, Snyder JJ, Foley RN, Collins AJ. Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us? Kidney Int Suppl 2006(103):S3-11.
4. Ahmad M, Robert R, Bargman JM, Oreopoulos D. Advantages of peritoneal dialysis in comparison to hemodialysis, in cardiac allograft recipients with end stage renal disease. Int Urol Nephrol 2008;40:1083-7.
5. Panagoutsos S, Kantartzi K, Passadakis P, Yannatos E, Mourvati E, Theodoridis M, et al. Timely transfer of peritoneal dialysis patients to hemodialysis improves survival rates. Clin Nephrol 2006;65:43-7.
6. Stack AG, Murthy BV, Molony DA. Survival differences between peritoneal dialysis and hemodialysis among "large" ESRD patients in the United States. Kidney Int 2004;65:2398-408.
7. Vonesh EF, Snyder JJ, Foley RN, Collins AJ. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int 2004;66:2389-401.
8. Stack AG, Molony DA, Rahman NS, Dosekun A, Murthy B. Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States. Kidney Int 2003;64:1071-9.
9. Ganesh SK, Hulbert-Shearon T, Port FK, Eagle K, Stack AG. Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol 2003; 14: 415-24.
10. Harris SA, Lamping DL, Brown EA, Constantinovici N. Clinical outcomes and quality of life in elderly patients on peritoneal dialysis versus hemodialysis. Perit Dial Int 2002;22:463-70.
11. Heaf JG, Lokkegaard H, Madsen M. Initial survival advantage of peritoneal dialysis relative to haemodiaiysis. Nephrol Dial Transplant 2002;17:112-7.
12. Avram MM, Sreedhara R, Fein P, Oo KK, Chattopadhyay J, Mittman N. Survival on hemodialysis and peritoneal dialysis over 12 years with emphasis on nutritional parameters. Am J Kidney Dis 2001;37(1 Suppl 2):S77-80.
13. Locatelli F, Marcelli D, Conte F, D'Amico M, Del Vecchio L, Limido A, et al. Survival and development of cardiovascular disease by modality of treatment in patients with end-stage renal disease. J Am Soc Nephrol 2001;12:2411-7.
14. Collins AJ, Hao W, Xia H, Ebben JP, Everson SE, Constantini EG, et al. Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis 1999;34:1065-74.
15. Litwin M, Kawalec W, Latoszynska J, Grenda R, Smirska E. Cardiac systolic and diastolic function in children on hemodialysis and continuous ambulatory peritoneal dialysis. Contrib Nephrol 1994; 106: 114-8.
16. Lee CC, Sun CY, Wu MS. Long-term modality-related mortality analysis in incident dialysis patients. Perit Dial Int 2009;29:182-90.
17. Wang AY, Lam CW, Chan IH, Wang M, Lui SF, Sanderson JE. Long-term mortality and cardiovascular risk stratification of peritoneal dialysis patients using a combination of inflammation and calcification markers. Nephrol Dial Transplant 2009 Jul 6.
18. McDonald SP, Marshall MR, Johnson DW, Polkinghorne KR. Relationship between dialysis modality and mortality. J Am Soc Nephrol 2009;20:155-63.
19. Jaar BG, Coresh J, Plantinga LC, Fink NE, Klag MJ, Levey AS, et al. Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med 2005;143:174-83.
20. Fenton SS, Schaubel DE, Desmeules M, Morrison HI, Mao Y, Copleston P, et al. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis 1997;30:334-42.
21. Liem YS, Wong JB, Hunink MG, de Charro FT, Winkelmayer WC. Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands. Kidney Int 2007;71:153-8.
22. Murphy SW, Foley RN, Barrett BJ, Kent GM, Morgan J, Barre P, et al. Comparative mortality of hemodialysis and peritoneal dialysis in Canada. Kidney Int 2000;57:1720-6.
23. Termorshuizen F, Korevaar JC, Dekker FW, Van Manen JG, Boeschoten EW, Krediet RT. Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis: analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis 2. J Am Soc Nephrol 2003;14:2851-60.
24. Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995;6:177-83.
25. Foley RN, Parfrey PS, Harnett JD, Kent GM, O'Dea R, Murray DC, et al. Mode of dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol 1998;9:267-76.
26. Held PJ, Port FK, Turenne MN, Gaylin DS, Hamburger RJ, Wolfe RA. Continuous ambulatory peritoneal dialysis and hemodialysis: comparison of patient mortality with adjustment for comorbid conditions. Kidney Int 1994;45:1163-9.
27. Nelson CB, Port FK, Wolfe RA, Guire KE. Comparison of continuous ambulatory peritoneal dialysis and hemodialysis patient survival with evaluation of trends during the 1980s. J Am Soc Nephrol 1992;3:1147-55.
28. Maiorca R, Vonesh EF, Cavalli P, De Vecchi A, Giangrande A, La Greca G, et al. A multicenter, selection-adjusted comparison of patient and technique survivals on CAPD and hemodialysis. Perit Dial Int 1991;11:118-27.
29. Maiorca R, Vonesh E, Cancarini GC, Cantaluppi A, Manili L, Brunori G, et al. A six-year comparison of patient and technique survivals in CAPD and HD. Kidney Int 1988;34:518-24.
30. Gokal R, Baillod R, Bogle S, Hunt L, Jakubowski C, Marsh F, et al. Multi-centre study on outcome of treatment in patients on continuous ambulatory peritoneal dialysis and haemodialysis. Nephrol Dial Transplant 1987;2:172-8.
31. Burton PR, Walls J. Selection-adjusted comparison of life-expectancy of patients on continuous ambulatory peritoneal dialysis, haemodialysis, and renal transplantation. Lancet 1987;1:1115-9.
32. Vonesh EF, Moran J. Mortality in end-stage renal disease: a reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1999;10:354-65.
33. Korevaar JC, Feith GW, Dekker FW, van Manen JG, Boeschoten EW, Bossuyt PM, et al. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int 2003;64:2222-8.
34. Gutman RA, Blumenkrantz MJ, Chan YK, Barbour GL, Gandhi VC, Shen FH, et al. Controlled comparison of hemodialysis and peritoneal dialysis: Veterans Administration multicenter study. Kidney Int 1984;26:459-70.
35. Stanley M. The CARI Guidelines Peritoneal Dialysis versus Haemodialysis. 2009.
36. Johnson DW, Dent H, Hawley CM, McDonald SP, Roseman JB, Brown FG, et al. Association of dialysis modality and cardiovascular mortality in incident dialysis patients. Clinical Journal American Society of Nephrology. 2009.
37. McDonald SPE, L. Livingston, B. Australian and NewZealand Dialysis and Transplant Registry. 2007.
38. Bakkaloglu SA, Saygili A, Sever L, Noyan A, Akman S, Ekim M, et al. Assessment of cardiovascular risk in paediatric peritoneal dialysis patients: a Turkish Pediatric Peritoneal Dialysis Study Group (TUPEPD) report. Nephrol Dial Transplant. 2009 Jun 18.
39. Civilibal M, Oflaz H, Caliskan S, Candan C, Canpolat N, Pehlivan G et al. Left ventricular systolic and diastolic function and carotid inti-ma-media thickness in pediatric dialysis patients. Int Urol Nephrol 2009;41:401-8.
40. Sezer S, Ozdemir N, Arat Z, Guz G, Sengul S, Akman B et al. What happens after conversion of treatment to continuous ambulatory peritoneal dialysis from hemodialysis? Adv Perit Dial 2000;16:177-81.
41. Jaar BG, Plantinga LC, Crews DC, Fink NE, Hebah N, Coresh J et al. Timing, causes, predictors and prognosis of switching from peritoneal dialysis to hemodialysis: a prospective study. BMC Nephrol 2009;10:3.
42. US Renal Data System. USRDS 2008 Annual Data Report. In: National Institute of Health NIoDaDaKD, editor. Bethesda; 2008.
43. Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 200521;353:238-48.
44. Chow KM, Szeto CC, Kwan BC, Chung KY, Leung CB, Li PK. Factors associated with sudden death in peritoneal dialysis patients. Perit Dial Int 2009;29:58-63.
45. Schurig R, Gahl GM, Becker H, Schiller R, Kessel M, Paeprer H. Hemodynamic studies in long-term peritoneal dialysis patients. Artif Organs 1979;3:215-8.
46. Schurig R, Gahl G, Schartl M, Becker H, Kessel M. Central and peripheral haemodynamics in longterm peritoneal dialysis patients. Proc Eur Dial Transplant Assoc 1979; 16:165-70.
47. Ivarsen P, Povlsen JV, Jensen JD. Increasing fill volume reduces cardiac performance in peritoneal dialysis. Nephrol Dial Transplant 2007;22:2999-3004.
48. Selby NM, Fonseca S, Hulme L, Fluck RJ, Taal MW, McIntyre CW. Hypertonic glucose-based peritoneal dialysate is associated with higher blood pressure and adverse haemodynamics as compared with icodextrin. Nephrol Dial Transplant 2005;20:1848-53.
49. Selby NM, Fonseca S, Hulme L, Fluck RJ, Taal MW, McIntyre CW. Automated peritoneal dialysis has significant effects on systemic hemodynamics. Perit Dial Int 2006;26:328-35.
50. Selby NM, Fialova J, Burton JO, McIntyre CW. The haemodynamic and metabolic effects of hypertonic-glucose and amino-acid-based peritoneal dialysis fluids. Nephrol Dial Transplant 2007;22:870-9.
51. Verbeke F, Van Biesen W, Pletinck A, Van Bortel LM, Vanholder R. Acute central hemodynamic effects of a volume exchange in peritoneal dialysis. Perit Dial Int 2008;28:142-8.
52. McIntyre CW. Acute cardiovascular functional effects of peritoneal dialysis: what do we know and why might it matter? Perit Dial Int 2008;28;123-5
53. Gao N, Kwan BC, Chow KM, Chung KY, Leung CB, Li PK, et al. Longitudinal changes of cardiothoracic ratio and vascular pedicle width as predictors of volume status during one year in Chinese peritoneal dialysis patients. Kidney Blood Press Res 2009;32:45-50.
54. Wu HY, Hung KY, Huang JW, Chen YM, Tsai TJ, Wu KD. Initial glucose load predicts technique survival in patients on chronic peritoneal dialysis. Am J Nephrol 2008;28:765-71.
55. Tsimihodimos V, Dounousi E, Siamopoulos KC. Dyslipidemia in chronic kidney disease: an approach to pathogenesis and treatment. Am J Nephrol 2008;28:958-73.
56. Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev 2009(3):CD004289.
57. Fellstrom BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009;360:1395-407.
58. Himmelfarb J, Hakim RM. Oxidative stress in uremia. Curr Opin Nephrol Hypertens. 2003;12:593-8.
59. Stenvinkel P. Inflammation in end-stage renal disease: the hidden enemy. Nephrology (Carlton) 2006;11:36-41.
60. Gusbeth-Tatomir P, Covic A. Causes and consequences of increased arterial stiffness in chronic kidney disease patients. Kidney Blood Press Res 2007;30:97-107.
61. Segall L, Covic A. Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro haemodialysis. Nephrol Dial Transplant 2007;22:59-63.
62. Van Biesen W, Verbeke F, Vanholder R. Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis. Nephrol Dial Transplant 2007;22:53-8.
63. Sigrist M, Bungay P, Taal MW, McIntyre CW. Vascular calcification and cardiovascular function in chronic kidney disease. Nephrol Dial Transplant 2006;21:707-14.
64. Yilmaz FM, Akay H, Duranay M, Yilmaz G, Oztekin PS, Kosar U, et al. Carotid atherosclerosis and cardiovascular risk factors in hemodialysis and peritoneal dialysis patients. Clin Biochem 2007;40:1361-6.
65. Furuya R, Kumagai H, Odamaki M, Takahashi M, Miyaki A, Hishida A. Impact of Residual Renal Function on Plasma Levels of Advanced Oxidation Protein Products and Pentosidine in Peritoneal Dialysis Patients. Nephron Clin Pract 2009;112:c255-c61.
66. Ayerden Ebinc F, Ebinc H, Derici U, Aral A, Aybay C, Tacoy G et al. The relationship between adiponectin levels and proinflammatory cytokines and left ventricular mass in dialysis patients. J Nephrol 2009;22:216-23.
67. Dursun I, H MP, Gunduz Z, Ulger H, Yykylmaz A, Dusunsel R et al. The relationship between circulating endothelial microparticles and arterial stiffness and atherosclerosis in children with chronic kidney disease. Nephrol Dial Transplant 2009 Feb 24.
68. Ueno H, Koyama H, Fukumoto S, Tanaka S, Shoji T, Emoto M et al. Dialysis modality is independently associated with circulating endothelial progenitor cells in end-stage renal diseases patients. Nephrol Dial Transplant. 2009 Jul 23.
69. Wang AY, Lam CW, Wang M, Chan 1H, Lui SF, Zhang Y et al. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients. Nephrol Dial Transplant 2009;24:1962-9.
70. Shah N, Bernardini J, Piraino B. Prevalence and correction of 25(OH) vitamin D deficiency in peritoneal dialysis patients. Perit Dial Int 2005;25:362-6.
71. Wang AY, Lam CW, Sanderson JE, Wang M, Chan IH, Lui SF et al. Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study. Am J Clin Nutr 2008;87:1631-8.
72. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999;99:2434-9.
73. Sutherland WH, Walker RJ, Ball MJ, Stapley SA, Robertson MC. Oxidation of low density lipoproteins from patients with renal failure or renal transplants. Kidney Int 1995;48:227-36.
74. Paragh G, Asztalos L, Seres I, Balogh Z, Locsey L, Karpati I et al. Serum paraoxonase activity changes in uremic and kidney-transplanted patients. Nephron 1999;83:126-31.
75. Massy ZA, Maziere C, Kamel S, Brazier M, Choukroun G, Tribouilloy C, et al. Impact of inflammation and oxidative stress on vascular calcifications in chronic kidney disease. Pediatr Nephrol 2005;20: 380-2.
76. Fang W, Yang X, Bargman JM, Oreopoulos DG. Association between pulse pressure and mortality in patients undergoing peritoneal dialysis. Perit Dial Int 2009;29:163-70.
77. Tang W, Cheng LT, Lu XH, Wang T. Effect of Nutrition on Arterial Stiffness in Peritoneal Dialysis Patients. Am J Nephrol 2009;30: 120-5.
78. Demirci MS, Ozkahya M, Asci G, Sevinc E, Yilmaz M, Demirci C et al. The influence of dialysate calcium on progression of arterial stiffness in peritoneal dialysis patients. Perit Dial Int 2009;29 Suppl 2: S15-7.
79. Wang AY. Vascular and other tissue calcification in peritoneal dialysis patients. Perit Dial Int 2009 Feb;29 Suppl 2:S9-S 14.
80. Stompor T, Pasowicz M, Sullowicz W, Dembinska-Kiec A, Janda K, Wojcik K, et al. An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis. Am J Kidney Dis 2003;41:203-11.
81. Ammirati AL, Dalboni MA, Cendoroglo M, Draibe SA, Santos RD, Miname M, et al. The progression and impact of vascular calcification in peritoneal dialysis patients. Perit Dial Int 2007;27:340-6.
82. Prasad N, Kumar S, Singh A, Sinha A, Chawla K, Gupta A et al. Carotid intimai thickness and flow-mediated dilatation in diabetic and nondiabetic continuous ambulatory peritoneal dialysis patients. Perit Dial Int 2009;29 Suppl 2:S96-S101.
83. Shigenaga A, Tamura K, Dejima T, Ozawa M, Wakui H, Masuda S et al. Effects of angiotensin II type 1 receptor blocker on blood pressure variability and cardiovascular remodeling in hypertensive patients on chronic peritoneal dialysis. Nephron Clin Pract 2009; 112:c31-40.
84. Krajewska M, Kosmala W, Weyde W, Madziarska K, Porazko T, Kopec W, et al. The effect of dialysis modality (PD and HD) on cardiac morphology and functions in chronic kidney disease patients at very high cardiovascular risk. Nephrol Dial Transplant 2008;23: 768-9.
85. Unal A, Sipahioglu M, Oguz F, Kaya M, Kucuk H, Tokgoz B, et al. Pulmonary hypertension in peritoneal dialysis patients: prevalence and risk factors. Perit Dial Int 2009;29:191-8.
86. Polner K, Gosi G, Vas SI, Kalina I, Acsady G. Management of abdominal aortic and iliac artery aneurysms by stent-graft implantation in a patient on CAPD. Clin Nephrol 2009;71:359-62.
87. Wang AY, Wang M, Woo J, Law MC, Chow KM, Li PK et al. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int 2002;62: 639-47.
88. Fassett RG, Driver R, Healy H, Ranganathan D, Ratanjee S, Robertson IK et al. Comparison of markers of oxidative stress, inflammation and arterial stiffness between incident hemodialysis and peritoneal dialysis patients-an observational study. BMC Nephrol 2009;10:8.
89. Piraino B. Cardiovascular Complications in Peritoneal Dialysis Patients. Contrib Nephrol 2009;163:102-9.
90. Lee HBS, K.I. Kim, J.H. Cha, M.K. Park, M.S. Dialysis in patients with diabetic nephropathy: CAPD versus hemodialysis. Peritoneal Dialysis International. 1996;16(Suppl-1):269-74.